Bazedoxifene/conjugated estrogens in combination with leuprolide for the treatment of endometriosis.

about

Bazedoxifene/conjugated estrogens in combination with leuprolide for the treatment of endometriosis.

Item

http://www.wikidata.org/entity/Q54980466

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Bazedoxifene/conjugated estrog ...... he treatment of endometriosis.

@en

Bazedoxifene/conjugated estrog ...... he treatment of endometriosis.

@nl

type

Item

label

Bazedoxifene/conjugated estrog ...... he treatment of endometriosis.

@en

Bazedoxifene/conjugated estrog ...... he treatment of endometriosis.

@nl

prefLabel

Bazedoxifene/conjugated estrog ...... he treatment of endometriosis.

@en

Bazedoxifene/conjugated estrog ...... he treatment of endometriosis.

@nl

P1476

Bazedoxifene/conjugated estrog ...... the treatment of endometriosis

@en

P2093

Bruce Lessey

http://www.w3.org/2001/XMLSchema#string

Hugh S Taylor

http://www.w3.org/2001/XMLSchema#string

Valerie A Flores

http://www.w3.org/2001/XMLSchema#string

P2860

Hormone therapy for endometriosis and surgical menopause

Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis

Oral contraceptives for pain associated with endometriosis

Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial.

Breast effects of bazedoxifene-conjugated estrogens: a randomized controlled trial.

Effects of bazedoxifene/conjugated estrogens on the endometrium and bone: a randomized trial.

Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show?

Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled Phase 3 study of postmenopausal women with osteoporosis.

Treatment with bazedoxifene and conjugated estrogens results in regression of endometriosis in a murine model.

Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model

P304

990-994

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1002/CCR3.1501

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Amanda M Hill

P577

2018-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29881549

http://www.w3.org/2001/XMLSchema#string

P921

endometriosis

P932

5986051

http://www.w3.org/2001/XMLSchema#string